Finance

Lists
VTR:NYSE
Ventas Inc
$ 82.04
+0.34%
(+0.28) 1D
$ 82.04
0.00% (0.00)
After hours
Closed: 10-р сарын 9, 16:01:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTR...
Open
$ 81.72
High
$ 82.94
Low
$ 81.33
Mkt. cap
42.08 тэрбум
Avg. vol.
3.76 сая
Volume
4.09 сая
Dividend
2.49%
Quarterly dividend
$ 0.51
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
150.52
52-wk high
$ 101.60
52-wk low
$ 66.92
EPS
$ 0.55
Beta
0.71
Shares outstanding
512.95 сая
No. of employees
542
Open
$ 81.72
High
$ 82.94
Low
$ 81.33
Mkt. cap
42.08 тэрбум
Avg. vol.
3.76 сая
Volume
4.09 сая
Dividend
2.49%
Quarterly dividend
$ 0.51
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
150.52
52-wk high
$ 101.60
52-wk low
$ 66.92
EPS
$ 0.55
Beta
0.71
Shares outstanding
512.95 сая
No. of employees
542
News stories
From web sources and news partners
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees542
Founded1983
HeadquartersЧикаго, Иллиной, Америкийн Нэгдсэн Улс
SectorReal estate investment trust
Analyst ratings
Based on 15 analysts giving stock ratings to VTR in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current $ 82.04
$ 113.00 (+37.74%)
Average
$ 99.93 (+21.81%)
Lowest
$ 72.00 (-12.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Juan C. Sanabria
BMO Capital
Buy
Reiterated
$ 107.00
+30.4%
10/02/2026
James Kammert
Evercore ISI
Buy
Maintained
$ 100.00
+21.9%
09/21/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
$ 112.00
+36.5%
09/16/2026
Joe Dickstein
Jefferies
Buy
Initiated
$ 102.00
+24.3%
09/15/2026
Michael Mueller
J.P. Morgan
Buy
Maintained
$ 104.00
+26.8%
09/03/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
$ 95.00
+15.8%
09/02/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
$ 104.00
+26.8%
09/01/2026
Richard Hightower
Barclays
Hold
Maintained
$ 102.00
+24.3%
08/31/2026
Michael Goldsmith
UBS
Hold
Reiterated
$ 93.00
+13.4%
08/21/2026
Michael Carroll
RBC Capital
Buy
Reiterated
$ 99.00
+20.7%
08/14/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
$ 90.00
+9.7%
08/13/2026
Nicholas Joseph
Citi
Buy
Maintained
$ 72.00
-12.2%
08/04/2026
Jeffrey Spector
Bank of America Securities
Buy
Reiterated
$ 113.00
+37.7%
08/03/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$ 102.00
+24.3%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$ 104.00
+26.8%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$ 114.00
+39%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
$ 94.00
+14.6%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
$ 94.00
+14.6%
06/16/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
$ 100.00
+21.9%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
$ 100.00
+21.9%
05/12/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
$ 95.00
+15.8%
05/07/2026
Marie Ferguson
Argus Research
Buy
Maintained
$ 88.00
+7.3%
02/09/2026
Last report
2026 оны 7-р сарын 30
Fiscal period
Q2 2026
$ 0.17 / $ 0.11
+51.73%beat
Revenue / Est. (USD)
1.72 тэрбум / 1.69 тэрбум
+1.92%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.50 тэрбум
1.55 тэрбум
1.65 тэрбум
1.72 тэрбум
Cost of goods sold
869.92 сая
937.40 сая
1.00 тэрбум
1.04 тэрбум
Cost of revenue
869.92 сая
937.40 сая
1.00 тэрбум
1.04 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.39 сая
41.01 сая
62.75 сая
46.99 сая
Operating expense
397.56 сая
297.53 сая
416.91 сая
422.70 сая
Total operating expenses
1.27 тэрбум
1.23 тэрбум
1.42 тэрбум
1.47 тэрбум
Operating income
233.98 сая
315.49 сая
226.81 сая
254.70 сая
Other non operating income
-13.37 сая
-4.20 сая
-9.70 сая
-4.45 сая
EBT including unusual items
62.36 сая
71.87 сая
43.11 сая
46.60 сая
EBT excluding unusual items
66.67 сая
164.69 сая
63.47 сая
91.99 сая
Income tax expense
-6.34 сая
-1.12 сая
-15.94 сая
-25.62 сая
Effective tax rate
-10.17%
-1.56%
-36.97%
-54.97%
Other operating expenses
-
-
-
-
Net income
66.05 сая
70.20 сая
55.91 сая
70.57 сая
Net profit margin
4.40%
4.53%
3.39%
4.10%
Earnings per share
0.12
0.13
0.10
0.17
Interest and investment income
4.18 сая
7.88 сая
2.50 сая
1.78 сая
Interest expense
-158.12 сая
-154.47 сая
-156.14 сая
-160.03 сая
Net interest expenses
-153.94 сая
-146.59 сая
-153.64 сая
-158.26 сая
Depreciation and amortization charges
357.17 сая
256.52 сая
354.17 сая
375.71 сая
EBITDA
559.73 сая
659.02 сая
585.75 сая
633.56 сая
Gain or loss from assets sale
-1.28 сая
-3.31 сая
-15.06 сая
-174.00 мян
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс